Latest Moxifloxacin Stories
DUBLIN, June 27, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/9kp9sq/ophthalmic_drugs)
-- Survey highlights interest in easing patient compliance issues associated with conventional post-cataract surgery eye drop regime -- SAN DIEGO, June 24, 2014 /PRNewswire/ --
LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
-- Imprimis' proprietary ophthalmic compounded formulations now available in 25 states and territories with a physician's prescription -- SAN DIEGO, May 28, 2014 /PRNewswire/ -- Imprimis
A Group of 50 Adverse Drug Reaction Victims Rally in Washington, DC Before Meeting with Members of Congress; Thousands Connect Via Online Support Groups Emerging Worldwide WASHINGTON,
LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
--First-time cataract formulation clinical data and clinical experience will be presented at a U.S. ophthalmic meeting -- SAN DIEGO, Feb.
In contrast to findings of a recent study, researchers in Denmark did not find an association between use of a class of antibiotics known as fluoroquinolones (such as ciprofloxacin) and an increased risk of retinal detachment.
Results of a new study suggest that three new diagnostic tests could each be used to successfully diagnose drug resistance in tuberculosis (TB) patients in a quarter of the time taken by the current method.